Stock GNPX GENPREX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Genprex, Inc.

Equities

GNPX

US3724462037

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
2.2 USD -0.45% Intraday chart for Genprex, Inc. -13.73% -76.09%
May. 14 Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa Immunogene Therapy in Combination with Tecentriq to Treat Small Cell Lung Cancer CI
May. 09 Genprex, Inc Announces Executive Changes CI
d86dc2a.5p0eF7eecUNQ94cXHrqcffALXnR0PXvQG0kmyPUXRV4.18V2Ifn_GQcplsZHQe3WMaM7bzszSTi-XhhSvcNiIzmo_FVP-_ILDhe70g~064c96228d78178fe6a9351f034a504d
  1. Stock Market
  2. Equities
  3. GNPX Stock
  4. Charts Genprex, Inc.
  5. News Chart